Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1979 4
1991 1
1993 1
1994 1
1995 2
1996 2
1997 1
1998 3
1999 6
2000 5
2001 3
2002 1
2003 3
2004 6
2005 8
2006 10
2007 13
2008 10
2009 14
2010 17
2011 15
2012 15
2013 16
2014 11
2015 11
2016 18
2017 40
2018 52
2019 21
2020 23
2021 21
2022 17
2023 22

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Results by year

Filters applied: . Clear all
Page 1
Hyper-IgE syndrome, 2021 update.
Minegishi Y. Minegishi Y. Allergol Int. 2021 Oct;70(4):407-414. doi: 10.1016/j.alit.2021.07.007. Epub 2021 Aug 18. Allergol Int. 2021. PMID: 34419355 Free article. Review.
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.
Otsubo K, Kishimoto J, Ando M, Kenmotsu H, Minegishi Y, Horinouchi H, Kato T, Ichihara E, Kondo M, Atagi S, Tamiya M, Ikeda S, Harada T, Takemoto S, Hayashi H, Nakatomi K, Kimura Y, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakagawa K, Nakanishi Y, Okamoto I. Otsubo K, et al. Among authors: minegishi y. Eur Respir J. 2022 Dec 15;60(6):2200380. doi: 10.1183/13993003.00380-2022. Print 2022 Dec. Eur Respir J. 2022. PMID: 35361630 Clinical Trial.
Hyper-IgE syndrome.
Minegishi Y. Minegishi Y. Curr Opin Immunol. 2009 Oct;21(5):487-92. doi: 10.1016/j.coi.2009.07.013. Epub 2009 Aug 28. Curr Opin Immunol. 2009. PMID: 19717292 Review.
X-linked agammaglobulinemia.
Conley ME, Rohrer J, Minegishi Y. Conley ME, et al. Among authors: minegishi y. Clin Rev Allergy Immunol. 2000 Oct;19(2):183-204. doi: 10.1385/CRIAI:19:2:183. Clin Rev Allergy Immunol. 2000. PMID: 11107501 Review. No abstract available.
Cutaneous manifestations of Hyper IgE syndrome.
Minegishi Y, Saito M. Minegishi Y, et al. Allergol Int. 2012 Jun;61(2):191-6. doi: 10.2332/allergolint.12-RAI-0423. Epub 2012 Mar 25. Allergol Int. 2012. PMID: 22441639 Free article. Review.
Diverged and Active Partitiviruses in Lichen.
Urayama SI, Doi N, Kondo F, Chiba Y, Takaki Y, Hirai M, Minegishi Y, Hagiwara D, Nunoura T. Urayama SI, et al. Among authors: minegishi y. Front Microbiol. 2020 Oct 21;11:561344. doi: 10.3389/fmicb.2020.561344. eCollection 2020. Front Microbiol. 2020. PMID: 33193146 Free PMC article.
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Minegishi Y, Akagami T, Arai M, Saito R, Arai D, Murase K, Miura K, Watanabe S, Sakashita H, Miyabayashi T, Honda R, Jingu D, Hotta T, Isobe K, Nakazawa K, Ito K, Takamura K, Inomata M, Harada T, Sakakibara R, Nakagawa T, Shibuya H, Takenaka K, Kobayashi K, Seike M. Minegishi Y, et al. Lung Cancer. 2022 Oct;172:1-8. doi: 10.1016/j.lungcan.2022.07.009. Epub 2022 Jul 26. Lung Cancer. 2022. PMID: 35952438 Review.
371 results